Abstract

Breast cancer (BC) is a type of cancer which progresses and spreads from breast tissues and gradually exceeds the entire body; this kind of cancer originates in both sexes. Prompt recognition of this disorder is most significant in this phase, and it is measured by providing patients with the essential treatment so their efficient lifetime can be protected. Scientists and researchers in numerous studies have initiated techniques to identify tumours in early phases. Still, misperception in classifying skeptical lesions can be due to poor image excellence and dissimilar breast density. BC is a primary health concern, requiring constant initial detection and improvement in analysis. BC analysis has made major progress recently with combining multi-modal image modalities. These studies deliver an overview of the segmentation, classification, or grading of numerous cancer types, including BC, by employing conventional machine learning (ML) models over hand-engineered features. Therefore, this study uses multi-modality medical imaging to propose a Computer Vision with Fusion Joint Transfer Learning for Breast Cancer Diagnosis (CVFBJTL-BCD) technique. The presented CVFBJTL-BCD technique utilizes feature fusion and DL models to effectively detect and identify BC diagnoses. The CVFBJTL-BCD technique primarily employs the Gabor filtering (GF) technique for noise removal. Next, the CVFBJTL-BCD technique uses a fusion-based joint transfer learning (TL) process comprising three models, namely DenseNet201, InceptionV3, and MobileNetV2. The stacked autoencoders (SAE) model is implemented to classify BC diagnosis. Finally, the horse herd optimization algorithm (HHOA) model is utilized to select parameters involved in the SAE method optimally. To demonstrate the improved results of the CVFBJTL-BCD methodology, a comprehensive series of experimentations are performed on two benchmark datasets. The comparative analysis of the CVFBJTL-BCD technique portrayed a superior accuracy value of 98.18% and 99.15% over existing methods under Histopathological and Ultrasound datasets.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.